Recent Updates on Microinjector based Suprachoroidal Gene Therapy: Potentials & Challenges
Time: 10:00 am
day: Post Conference Day
Details:
- SCS microinector based suprachoroidal gene delivery enables minimally invasive
office-based treatment for choroiretinal diseases - Nanoparticle based non-viral gene delivery via SC injection has potential to be a
repeatable office-based gene therapy
